臀股脂肪组织对脑血管病的有益作用:因果通路与中介分析
本研究利用UK Biobank数据,通过孟德尔随机化分析BMI非依赖的脂肪分布与脑血管病风险的因果关联。结果显示遗传预测的臀股脂肪体积增加与缺血性卒中、大动脉卒中及小血管卒中风险降低相关,且该保护作用主要由常见血管危险因素介导,脂肪组织特异性因子如脂联素也介导部分风险。
要点
- 遗传预测的臀股脂肪体积每增加1个标准差,缺血性卒中风险OR 0.92(95%CI 0.86-0.98)。
- 臀股脂肪体积增加与大动脉卒中(OR 0.80)和小血管卒中(OR 0.77)风险降低相关。
- 腹内脂肪和腹部皮下脂肪与缺血性卒中风险无显著关联。
核心结论
- 本研究支持臀股分布脂肪体积对脑血管病风险具有保护作用。
- 该保护作用主要由常见血管危险因素介导,脂肪组织特异性因子可能起中介效应。
研究设计与样本
- 研究选取UK Biobank中与BMI非依赖的内脏脂肪、腹部皮下脂肪和臀股脂肪体积相关的遗传变异,进行单变量和多变量孟德尔随机化分析。
- 研究结局包括缺血性卒中及其亚型(大动脉卒中、心源性栓塞卒中、小血管卒中),并采用冠状动脉疾病、颈动脉内膜中层厚度和MRI证实的腔隙性卒中作为阳性对照。
- 通过两步中介孟德尔随机化分析探索常见心血管因素、胰岛素抵抗、炎症因子和脂肪组织特异性因子的中介作用。
主要发现
- 遗传预测的臀股脂肪体积增加与缺血性卒中风险降低相关(OR 0.92,95%CI 0.86-0.98),与大动脉卒中(OR 0.80,95%CI 0.66-0.96)和小血管卒中(OR 0.77,95%CI 0.67-0.88)风险降低相关,但与心源性栓塞卒中无显著关联。
- 遗传预测的臀股脂肪体积增加与冠状动脉疾病风险降低(OR 0.82,95%CI 0.76-0.88)、腔隙性卒中风险降低(OR 0.78,95%CI 0.67-0.92)及平均颈动脉内膜中层厚度降低(β = -0.073,95%CI -0.114至-0.031)相关。
- 遗传预测的腹部皮下脂肪或内脏脂肪与缺血性卒中风险无显著关联。
- 脂联素介导了臀股脂肪体积与缺血性卒中风险的约15%(1.8%-57%)及与冠状动脉疾病风险的约4.6%(0.8%-13.5%)。
临床怎么用
- 研究结果提示臀股分布脂肪体积可能对脑血管病风险具有保护作用,但此发现基于孟德尔随机化分析,尚需进一步研究验证其临床意义。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Previous studies have shown that increased body fat is associated with stroke risk, with evidence suggesting that body fat distribution, rather than total body fat, exerts a more prominent role in cerebrovascular risk prediction. In this study, we explore causal associations between body mass index (BMI)-independent adipose tissue distribution profiles and cerebrovascular disease (CVD) risk, aiming to refine the association between body fat distribution and stroke. METHODS: We selected variants associated with BMI-independent visceral adipose tissue (VAT), abdominal subcutaneous adipose tissue (ASAT), and gluteofemoral adipose tissue (GFAT) volumes in UK Biobank, and performed univariable and multivariable Mendelian randomization (MR) analyses with ischemic stroke (IS) and subtypes (large artery stroke [LAS], cardioembolic stroke [CES], and small vessel stroke [SVS]). We used coronary artery disease (CAD), carotid intima media thickness (cIMT), and MRI-confirmed lacunar stroke as positive controls. We explored the mediatory role of common cardiovascular (systolic blood pressure, diabetes, and low-density lipoprotein), insulin resistance, inflammatory (C-reactive protein), and adipose tissue-specific (adiponectin, leptin) factors by performing 2-step mediation MR analyses. Estimates were expressed per standard deviation increase in adjusted adipose tissue volume. RESULTS: Genetic predisposition to higher GFAT volume was associated with lower risk of IS (odds ratio [OR] 0.92, 95% CI 0.86-0.98), LAS (OR 0.80, 95% CI 0.66-0.96), and SVS (OR 0.77, 95% CI 0.67-0.88), but not CES, consistent in multivariable analyses. Genetic predisposition to higher GFAT volume was also associated with lower risk of CAD (OR 0.82, 95% CI 0.76-0.88), lacunar stroke (OR 0.78, 95% CI 0.67-0.92), and mean cIMT (β = -0.073, 95% CI -0.114 to -0.031). Associations were largely consistent in sensitivity analyses. No association was observed between genetic predisposition to ASAT or VAT and IS risk. Although common vascular risk factors were the predominant mediators in the GFAT-CVD axis, adiponectin and leptin mediated a proportion of IS and CAD risk (∼15% (1.8%-57%) and ∼4.6% (0.8%-13.5%) mediated by adiponectin, respectively). DISCUSSION: This study supports a protective role of gluteofemorally distributed fat volume in CVD risk. Although this role is predominantly mediated by common vascular risk factor modification, adipose tissue-specific factors may exert a mediatory effect, suggesting a possible novel target for attenuating adiposity-related CVD risk.
引用
- Myserlis EP, Georgakis MK, Parodi L, et al. A Beneficial Role for Gluteofemoral Adipose Tissue in Cerebrovascular Disease: Causal Pathway and Mediation Analysis. Neurology. 2025. PMID: 40228186. doi:10.1212/WNL.0000000000213573
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。